
Loading, please wait...

Loading, please wait...

Periventricular nodular heterotopia (PVNH) represents a complex malformation of cortical development. In fact, research into periventricular nodular heterotopia genetics has revealed that aberrant neuronal migration leads to clusters of neurons in the subependymal region. Consequently, these abnormal clusters often trigger genetic epilepsy. Although seizures can occur shortly after birth, they most frequently emerge during the second decade of life. Notably, generalized tonic-clonic seizures are the most common manifestation observed in clinical practice.
Historically, clinicians have identified the FLNA gene as the primary driver of this condition. This X-linked gene plays a critical role in actin-binding and cell motility. However, recent studies emphasize that PVNH is a highly genetically heterogeneous disease. Therefore, identifying additional risk genes is essential for better patient outcomes. Genes such as ARFGEF2, MAP1B, and NEDD4L have also been implicated in the pathogenesis of PVNH. Furthermore, these discoveries highlight that various molecular pathways can lead to similar pathological manifestations.
Human cerebral organoids and animal models provide significant insights into the pathogenesis of this disorder. These models allow researchers to observe how specific gene products affect brain development. In addition, advanced neuroimaging remains the gold standard for identifying subependymal nodules. Since many variants are understudied, an updated spectrum of risk genes is vital for precision medicine. Thus, ongoing research continues to expand our understanding of how these genetic changes lead to epilepsy and developmental anomalies.
The most common symptom is epilepsy, particularly generalized tonic-clonic seizures. Many patients remain asymptomatic until their teenage years, when seizures typically begin.
PVNH is often inherited in an X-linked dominant pattern associated with the FLNA gene. However, it can also follow autosomal recessive or de novo patterns depending on the specific gene variant involved.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Song J et al. Gene variants in periventricular nodular heterotopia. Acta Epileptol. 2026 May 02. doi: undefined. PMID: 42067951.
Guerrini R, Parrini E. Neuronal migration disorders. Neurobiol Dis. 2023.
Parrini E et al. Genetic Heterogeneity of Periventricular Nodular Heterotopia. Front Cell Neurosci. 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of genetic variants in periventricular nodular heterotopia (PVNH), focusing on FLNA and emerging risk genes associated with epilepsy....
2 months ago

A JAMA study using Global Burden of Disease 2023 data reveals high LDL cholesterol caused 3.6 million deaths globally, with India and China bearing one-third of the disease burden. Addressing systemic barriers to statin therapy and strengthening primary care lipid screening remain critical clinical priorities.
Today

The National Human Rights Commission has directed the Rajasthan government to act on maternal deaths and severe injuries in Kota linked to substandard oxytocin injections. The intervention follows complaints regarding batch quality failures, acute renal injury requiring dialysis, and regulatory oversights.
Today

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
Last week

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
Last week

A comprehensive review highlights major modifiable dementia risk factors in India, emphasizing early-onset diabetes, sensory deficits, undernutrition, and lifestyle interventions to protect cognitive health across diverse populations.
Yesterday